Recall of EpiPen 300 - 20 March 2017

Recall of EpiPen 300 - 20 March 2017

All EpiPens with an April 2017 expiry date are being recalled because of a possible defect that may result in difficulty activating the device in an emergency.

This recall is being conducted by Alphapharm in consultation with the Australian Therapeutic Goods Administration(TGA). Alphapharm Initiates Recall of EpiPen® Auto-Injector in Australia EpiPen® 300 microgram (μg) Adrenaline Injection Syringe Auto-InjectorBatches 5FA665, 5FA6651, 5FA6652, 5FA6653 Alphapharm Pty Ltd, following consultation with the Therapeutic Goods Administration, is recalling the following batches of EpiPen® 300 microgram (μg) Adrenaline Injection Syringe Auto-Injectors due to the potential that these devices may contain a defective part that may result in the device failing to activate or requiring increased force to activate. Batch number Expiry 5FA665 Apr 17 5FA6651 Apr 17 5FA6652 Apr 17 5FA6653 Apr 17

Information provided as per Allergy & Anaphylaxis Australia (A&AA) website media releases More information HERE and HERE

#latest #Community


COMMENTS : You can use a pen name or better yet use your real name, you must provide a valid email address (that does not get published) and your comment will be moderated prior to approval (or rejection if that is the determination of the moderator). Refer to our Terms and Conditions if you have any questions) 

Please note that from time to time comments are archived. If you are looking for a previous comment no longer visible please contact us. Last Archived 7th July 2019